HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Xiang Chen Selected Research

Threonine (L-Threonine)

3/2015Phosphorylation of innate immune adaptor proteins MAVS, STING, and TRIF induces IRF3 activation.
1/2012Inhibition of lymphatic metastases by a survivin dominant-negative mutant.
6/2010Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
1/2010Enhanced tumor radiosensitivity by a survivin dominant-negative mutant.
1/2010Enhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.
3/2006Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Xiang Chen Research Topics

Disease

66Neoplasms (Cancer)
11/2015 - 06/2002
20Neoplasm Metastasis (Metastasis)
06/2015 - 06/2002
13Melanoma (Melanoma, Malignant)
08/2015 - 06/2002
9Infection
03/2015 - 05/2006
8Osteosarcoma (Osteogenic Sarcoma)
04/2015 - 11/2008
7Carcinoma (Carcinomatosis)
02/2015 - 12/2008
7Myopia
09/2013 - 12/2008
6Psoriasis (Pustulosis Palmaris et Plantaris)
08/2015 - 12/2011
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2015 - 11/2008
6Breast Neoplasms (Breast Cancer)
09/2013 - 08/2008
5Lung Neoplasms (Lung Cancer)
01/2015 - 03/2009
4Bites and Stings (Sting)
10/2015 - 02/2013
4Inflammation
09/2015 - 06/2011
4Leukemia
04/2015 - 01/2013
4Alzheimer Disease (Alzheimer's Disease)
01/2015 - 03/2010
4Stroke (Strokes)
01/2015 - 08/2014
4Insulin Resistance
07/2013 - 12/2008
3Anoxia (Hypoxia)
10/2015 - 01/2013
3Osteoporosis
09/2015 - 06/2011
3Bovine Tuberculosis
02/2015 - 01/2015
3Brain Injuries (Brain Injury)
01/2015 - 10/2014
3Hemangioma (Angioma)
01/2015 - 08/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2014 - 08/2012
3Diabetes Mellitus
08/2012 - 01/2005
3Refractive Errors (Refractive Error)
01/2011 - 01/2010
3Type 2 Diabetes Mellitus (MODY)
12/2010 - 12/2008
3Lewis Lung Carcinoma
06/2010 - 12/2008
2Retinoblastoma (Glioblastoma, Retinal)
12/2015 - 01/2014
2Neuroblastoma
11/2015 - 03/2012
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2015 - 04/2010
2Obesity
09/2015 - 06/2011
2Insulinoma
05/2015 - 05/2011
2Brain Ischemia (Cerebral Ischemia)
10/2014 - 06/2008
2Ovarian Neoplasms (Ovarian Cancer)
05/2014 - 12/2013
2Diarrhea
02/2014 - 07/2008
2Edema
02/2014 - 07/2008
2Renal Cell Carcinoma (Grawitz Tumor)
01/2014 - 09/2006
2Pheochromocytoma
01/2014 - 07/2012
2Lymphoma (Lymphomas)
01/2014 - 08/2008
2Astigmatism
09/2013 - 08/2012

Drug/Important Bio-Agent (IBA)

13DNA (Deoxyribonucleic Acid)IBA
10/2015 - 06/2010
13Liposomes (Liposome)IBA
06/2014 - 05/2009
9Small Interfering RNA (siRNA)IBA
10/2013 - 12/2006
7Transcription Factors (Transcription Factor)IBA
08/2015 - 01/2011
7Insulin (Novolin)FDA Link
07/2013 - 12/2008
6Proteins (Proteins, Gene)IBA
11/2015 - 08/2010
6Carbon MonoxideIBA
06/2015 - 06/2010
6Threonine (L-Threonine)FDA Link
03/2015 - 03/2006
6CD147 Antigens (Basigin)IBA
12/2014 - 06/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2014 - 12/2006
61,2- dioleoyloxy- 3- (trimethylammonium)propaneIBA
01/2012 - 05/2009
5Phosphotransferases (Kinase)IBA
03/2015 - 08/2012
5Matrix MetalloproteinasesIBA
12/2014 - 06/2002
4Messenger RNA (mRNA)IBA
10/2015 - 08/2010
4MicroRNAs (MicroRNA)IBA
04/2015 - 01/2014
4ParaffinIBA
04/2015 - 08/2003
4RNA (Ribonucleic Acid)IBA
04/2015 - 12/2006
4NF-kappa B (NF-kB)IBA
01/2014 - 12/2008
4Paclitaxel (Taxol)FDA LinkGeneric
01/2012 - 07/2010
4Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2012 - 07/2010
3Formaldehyde (Formol)FDA Link
04/2015 - 03/2012
3AntigensIBA
02/2015 - 12/2012
3Amyloid (Amyloid Fibrils)IBA
01/2015 - 09/2012
3Propranolol (Inderal)FDA LinkGeneric
01/2015 - 08/2014
3Anti-Bacterial Agents (Antibiotics)IBA
07/2014 - 09/2009
3InterferonsIBA
02/2013 - 05/2006
3CholesterolIBA
01/2012 - 12/2010
3Doxorubicin (Adriamycin)FDA LinkGeneric
07/2010 - 08/2008
3Alanine (L-Alanine)FDA Link
06/2010 - 01/2010
2Cyclic GMPIBA
10/2015 - 02/2013
2CytokinesIBA
10/2015 - 04/2010
2Adenosine Monophosphate (AMP)IBA
10/2015 - 02/2013
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2015 - 06/2011
2Complementary DNA (cDNA)IBA
06/2015 - 01/2011
2Serine (L-Serine)FDA Link
03/2015 - 03/2006
2Interferon Type IIBA
03/2015 - 01/2013
2ProteomeIBA
03/2015 - 11/2008
2Transforming Growth Factor beta (TGF-beta)IBA
02/2015 - 06/2011
2Interferon-gamma (Interferon, gamma)IBA
02/2015 - 01/2015
2malibatol AIBA
01/2015 - 01/2015
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2014 - 01/2010
2HMGB1 Protein (HMG1)IBA
08/2014 - 04/2010
2Carrier Proteins (Binding Protein)IBA
05/2014 - 01/2014
2Biological Markers (Surrogate Marker)IBA
05/2014 - 01/2010
2Virulence Factors (Pathogenicity Factors)IBA
02/2014 - 07/2008
2Cisplatin (Platino)FDA LinkGeneric
01/2014 - 01/2010
2PeptidesIBA
01/2014 - 11/2009
2UbiquitinIBA
12/2013 - 04/2011
2Glycoproteins (Glycoprotein)IBA
10/2013 - 11/2008
2CalciumIBA
10/2013 - 10/2003

Therapy/Procedure

10Heterologous Transplantation (Xenotransplantation)
11/2015 - 10/2007
8Radiotherapy
07/2015 - 12/2008
6Drug Therapy (Chemotherapy)
11/2015 - 07/2009
5Lenses
09/2013 - 01/2009
5Transplantation (Transplant Recipients)
06/2013 - 10/2007
4Intravenous Injections
06/2014 - 01/2010
3Therapeutics
11/2015 - 01/2011
3Stents
01/2014 - 01/2011
3Eyeglasses (Spectacles)
08/2012 - 09/2010
2Contact Lenses
09/2013 - 01/2011